Valsartan, Cardiac Outcome and Blood Pressure Control

Author： Bruno Trimarco   Carmine Morisco   Andrea Petretta  

Publisher： Adis International

ISSN： 1120-9879

Source： High Blood Pressure & Cardiovascular Prevention, Vol.11, Iss.3, 2004-01, pp. : 113-115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood pressure control with valsartan and hydrochlorothiazide in clinical practice: The MACHT Observational Study

By Abts Markus   Claus Volker   Lataster Marcos  

Blood Pressure, Vol. 15, Iss. 1, 2006-03 ,pp. : 27-32

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy

By Tuomilehto Jaakko   Tykarski Andrzej   Baumgart Peter   Reimund Bernard   Breton Stephanie Le   Ferber Philippe  

Blood Pressure, Vol. 17, Iss. 1, 2008-06 ,pp. : 15-23

Informa Healthcare

Access to resources Recommend Favorite

Achieving better blood pressure control

By Hedner Thomas   Oparil Suzanne   Narkiewicz Krzysztof   Kjeldsen Sverre  

Blood Pressure, Vol. 17, Iss. 1, 2008-06 ,pp. : 3-4

Informa Healthcare

Access to resources Recommend Favorite

Blood Pressure Control and Diabetic Retinopathy

By  

Current Hypertension Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 241-244

Bentham Science Publishers

Access to resources Recommend Favorite

Blood Pressure Control and Antihypertensive Treatment

By  

Current Vascular Pharmacology, Vol. 10, Iss. 4, 2012-07 ,pp. : 506-511

Bentham Science Publishers

Access to resources Recommend Favorite